Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of 68Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer

Cancer statistics, 2019

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 20.7K citations · Full text

Epidemiology Of Cancer, Population Health Sciences, Health Disparities +19

⁶⁸Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

Matthias Eder, Martin Schäfer, Ulrike Bauder‐Wüst et al. · Bioconjugate Chemistry · 2012 · 824 citations

Engineering, Imaging Agent, Urea-based Inhibitors +19

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 737 citations

Joint Eanm, Oncologic Imaging, Medical Imaging +10

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Matthias Eiber, Ken Herrmann, Jérémie Calais et al. · Journal of Nuclear Medicine · 2017 · 574 citations · Full text

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.

Jeffrey S. Ross, Christine E. Sheehan, Hugh A.�G. Fisher et al. · PubMed · 2003 · 506 citations